Stock-Based Compensation - Stock Option Activity (Details) - USD ($) $ / shares in Units, $ in Thousands	1 Months Ended	9 Months Ended	12 Months Ended
	Jun. 30, 2022	Jun. 30, 2022	Jun. 30, 2023	May 16, 2022
Equity Incentive Plan 2022
Weighted Average Grant Date Fair Value
Maximum number of shares authorized (in shares)				4,564,508
2022 Employee Stock Purchase Plan
Weighted Average Grant Date Fair Value
Maximum number of shares authorized (in shares)			154,174	184,010
Purchase price of common stock, percent	85.00%
Stock Options
Stock options activity
Outstanding, beginning of period (in shares)	1,326,860	0	1,175,853
Granted (in shares)			208,361
Exercised (in shares)		(62,250)	(347,238)
Cancelled / Forfeited (in shares)		(3,447)	(31,150)
Outstanding, end of period (in shares)	1,175,853	1,175,853	1,005,826
Vested and exercisable, end of period (in shares)			643,086
Vested and expected to vest, end of period (in shares)			983,744
Weighted Average Exercise Price
Outstanding, beginning of period (in dollars per share)		$ 0	$ 120.03
Granted (in dollars per share)		193.35	205.46
Exercised (in dollars per share)		93.32	96.12
Cancelled / Forfeited (in dollars per share)		138.78	178.39
Outstanding, end of period (in dollars per share)	$ 120.03	$ 120.03	144.17
Vested and exercisable, end of period (in dollars per share)			125.00
Vested and expected to vest, end of period (in dollars per share)			$ 143.36
Weighted Average Remaining Contractual Term
Outstanding, end of period		7 years 21 days	6 years 5 months 8 days
Vested and exercisable, end of period			5 years 5 months 1 day
Vested and expected to vest, end of period			6 years 4 months 20 days
Aggregate Intrinsic Value
Outstanding, beginning of period		$ 0	$ 75,597
Outstanding, end of period	$ 75,597	$ 75,597	32,935
Vested and exercisable, end of period			29,872
Vested and expected to vest, end of period			$ 32,719
Weighted Average Grant Date Fair Value
Expected life (in years)		5 years 2 months 12 days	4 years 9 months 18 days
Weighted average fair value (in dollars per share)		$ 71.90	$ 79.02
Risk-free interest rate (as a percent)		3.00%	3.40%
Expected dividend yield (as a percent)		0.00%	0.00%
Expected volatility factor (as a percent)		36.10%	38.20%
Stock Options | Minimum
Weighted Average Grant Date Fair Value
Contractual terms			7 years
Stock Options | Maximum
Weighted Average Grant Date Fair Value
Contractual terms			10 years
Restricted Stock Units
Stock options activity
Outstanding, beginning of period (in shares)	504,386
Restricted stock units activity
Outstanding, beginning of period (in shares)		0	484,544
Granted (in shares)			257,773
Settled (in shares)		(87,930)	(244,161)
Cancelled / Forfeited (in shares)		(5,149)	(41,788)
Outstanding, end of period (in shares)	484,544	484,544	456,368
Vested and expected to vest (in shares)			390,284
Weighted Average Grant Date Fair Value
Outstanding, beginning of period (in dollars per share)		$ 0	$ 188.45
Granted (in dollars per share)		193.70	201.59
Settled (RSUs) (in dollars per share)		188.32	193.72
Cancelled / Forfeited (in dollars per share)		184.62	194.48
Outstanding, end of period (in dollars per share)	$ 188.45	$ 188.45	$ 192.55
Vested and expected to vest, end of period (in dollars per share)			192.37
Total fair value of shares vested from RSU grants		$ 46,600	$ 50,500
Share-based Payment Arrangement [Member]
Stock options activity
Granted (in shares)		76,056
Weighted Average Exercise Price
Granted (in dollars per share)		$ 193.55
Restricted stock units activity
Granted (in shares)		124,226
Weighted Average Grant Date Fair Value
Granted (in dollars per share)		$ 193.70
Share-based Payment Arrangement [Member] | Emerson stock-based compensation plans
Stock options activity
Granted (in shares)		1,165,494
Weighted Average Exercise Price
Granted (in dollars per share)		$ 101.44
Restricted stock units activity
Granted (in shares)		453,397
Weighted Average Grant Date Fair Value
Granted (in dollars per share)		$ 166.30